Albemarle (NYSE:ALB - Get Free Report) released its quarterly earnings data on Wednesday. The specialty chemicals company reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.53 by $0.05, FiscalAI reports. Albemarle had a net margin of 3.09% and a return on equity of 10.96%. The company had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.52 billion.
Albemarle Stock Up 5.9%
Shares of NYSE ALB traded up $5.31 during midday trading on Wednesday, reaching $95.50. 6,047,852 shares of the company's stock were exchanged, compared to its average volume of 2,466,557. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.35 and a current ratio of 2.09. Albemarle has a 52-week low of $89.10 and a 52-week high of $221.00. The business's fifty day moving average price is $109.81 and its two-hundred day moving average price is $148.95. The stock has a market capitalization of $11.27 billion, a PE ratio of 353.71, a price-to-earnings-growth ratio of 0.54 and a beta of 1.34.
Albemarle Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Friday, December 18th will be given a dividend of $0.41 per share. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Friday, December 18th. Albemarle's payout ratio is presently 607.41%.
Analyst Ratings Changes
ALB has been the topic of several recent research reports. BMO Capital Markets restated an "outperform" rating and set a $175.00 target price on shares of Albemarle in a report on Tuesday, October 6th. Weiss Ratings cut shares of Albemarle from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Friday, October 23rd. UBS Group lowered their price target on Albemarle from $175.00 to $150.00 and set a "buy" rating for the company in a report on Monday, October 5th. Citigroup lowered their price target on Albemarle from $175.00 to $125.00 and set a "buy" rating for the company in a report on Thursday, October 22nd. Finally, JPMorgan Chase & Co. cut their price objective on Albemarle from $160.00 to $140.00 and set a "neutral" rating on the stock in a research report on Tuesday, August 25th. Fifteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $179.41.
Read Our Latest Analysis on ALB
About Albemarle
(
Get Free Report)
Albemarle Corporation NYSE: ALB is a global specialty chemicals company headquartered in Charlotte, North Carolina. The company develops, manufactures, and markets engineered chemicals used in energy storage, transportation, refining, pharmaceuticals, agriculture, consumer products, and other industrial applications.
Albemarle is one of the world's major producers of lithium and supplies lithium compounds, including lithium carbonate and lithium hydroxide, for use in rechargeable batteries for electric vehicles, portable electronics, and grid energy-storage systems.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Albemarle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.
While Albemarle currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.